Rhenman & Partners Asset Management Ab Outset Medical, Inc. Transaction History

Rhenman & Partners Asset Management Ab

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$10.52 - $20.68 $526,000 - $1.03 Million	50,000 New	50,000 $544,000
Q2 2023 Aug 11, 2023	SELL	$17.18 - $23.76 $3.94 Million - $5.45 Million	-229,365 Reduced 40.96%	330,635 $7.23 Million
Q1 2023 May 11, 2023	BUY	$18.25 - $30.26 $3.65 Million - $6.05 Million	200,000 Added 55.56%	560,000 $10.3 Million
Q4 2022 Feb 13, 2023	BUY	$12.36 - $26.41 $247,200 - $528,200	20,000 Added 5.88%	360,000 $9.3 Million
Q3 2022 Nov 14, 2022	BUY	$14.67 - $21.7 $2.35 Million - $3.47 Million	160,000 Added 88.89%	340,000 $5.28 Million

Q2 2022 Aug 12, 2022	BUY	$13.46 - $48.16 $2.42 Million - $8.67 Million	180,000 New	180,000 $2.68 Million

122

41M

63.4K

32.1K

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $181M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.